胆道支架在等待胆囊切除术患者胆道结石清除后结石复发及并发症中的作用:一项随机试验
这项随机对照试验纳入同时患有胆囊结石和胆总管结石、经内镜逆行胆管造影(ERC)确认胆总管结石已清除的患者,比较预防性胆道支架置入与不置入支架在等待胆囊切除术期间的效果。结果显示,支架组并发症发生率显著高于无支架组(P=0.024),而胆总管结石复发率两组无显著差异(P=0.306)。
要点
- 支架组7/34(20.6%)与无支架组3/34(9.4%)胆总管结石复发,差异无统计学意义(P=0.306)。
- 支架组5例出现并发症(2例胆囊炎、3例ERC后胰腺炎),无支架组0例,差异有统计学意义(P=0.024)。
- 两组均无患者需要急诊ERC。
核心结论
- 预防性胆道支架置入在等待胆囊切除术患者中未显示降低胆总管结石复发的作用,且并发症发生率更高。
研究设计与样本
- 随机对照试验,2021年9月至2022年7月纳入70例同时患有胆囊结石和胆总管结石、经ERC下阻断胆管造影确认胆总管结石已清除的患者,随机分为支架组(n=35)和无支架组(n=35),最终66例纳入分析。
主要发现
- 10例(15.2%)患者出现胆总管结石复发,支架组7/34(20.6%)vs 无支架组3/34(9.4%),P=0.306。
- 支架组5例(2例胆囊炎、3例ERC后胰腺炎)出现并发症,无支架组0例,P=0.024。
- 两组均无患者需要急诊ERC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The role of prophylactic biliary stenting after clearance of choledocholithiasis in patients awaiting cholecystectomy for concomitant cholelithiasis is controversial. We planned a randomized controlled trial to study the effect of prophylactic biliary stenting after achieving biliary clearance in reducing recurrence of choledocholithiasis and biliary complications in patients awaiting cholecystectomy. METHODS: Patients with concomitant cholelithiasis and choledocholithiasis were included, and those who had evidence of clearance of choledocholithaisis (documented on occlusion cholangiogram during endoscopic retrograde cholangiography [ERC]) were randomized to prophylactic biliary stenting or no stenting. Choledocholithaisis recurrence rate (primary outcome), biliary complications and need for repeat/emergency ERC (secondary outcomes) were compared till 3 months after clearance. RESULTS: Between September 2021 and July 2022, 70 patients were randomized into group A, stenting (n = 35), and group B, no stenting (n = 35). Sixty-six patients were included in the final analysis. Baseline characteristics were comparable between the 2 groups. Ten (15.2%) patients had recurrence of choledocholithiasis, and it was comparable between the 2 groups (7/34 [20.6%] and 3/34 [9.4%], P = 0.306). Five patients (2 cholecystitis and 3 post-ERC pancreatitis) from the stent group while none from the no stent group developed complications, and this difference was statistically significant ( P = 0.024). None of the patients in both the groups needed emergency ERC during the follow-up. DISCUSSION: This randomized trial shows a higher complication rate with prophylactic stenting, while there is no benefit in preventing choledocholithiasis recurrence in patients waiting for cholecystectomy after biliary clearance (CTRI registration number: CTRI/2021/09/036538).
引用
- Sasani A, Mandavdhare HS, Sharma V, et al. Role of Biliary Stent in Recurrence of Biliary Stones and Complications After Stone Clearance in Patients Awaiting Cholecystectomy: A Randomized Trial. Am J Gastroenterol. 2023. PMID: 37561074. doi:10.14309/ajg.0000000000002471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。